KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Consolidated Net Income (2019 - 2025)

Historic Consolidated Net Income for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • GoodRx Holdings' Consolidated Net Income fell 7177.81% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.8 million, marking a year-over-year increase of 29578.27%. This contributed to the annual value of $16.4 million for FY2024, which is 28482.18% up from last year.
  • GoodRx Holdings' Consolidated Net Income amounted to $1.1 million in Q3 2025, which was down 7177.81% from $12.8 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Consolidated Net Income high stood at $58.8 million for Q2 2023, and its period low was -$41.7 million during Q3 2022.
  • Moreover, its 5-year median value for Consolidated Net Income was $1.1 million (2025), whereas its average is -$1.3 million.
  • Within the past 5 years, the most significant YoY rise in GoodRx Holdings' Consolidated Net Income was 425448.76% (2023), while the steepest drop was 121181.54% (2023).
  • GoodRx Holdings' Consolidated Net Income (Quarter) stood at -$39.9 million in 2021, then skyrocketed by 95.06% to -$2.0 million in 2022, then plummeted by 1211.82% to -$25.9 million in 2023, then surged by 126.05% to $6.7 million in 2024, then tumbled by 83.4% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $12.8 million for Q2 2025, and $11.1 million during Q1 2025.